Nonalcoholic fatty liver disease is one of the most common liver diseases in the world. Understanding how certain factors affect the progression of fatty liver disease — such as diet and the types of bacteria that live in the stomach — helps us better tailor therapies for those most at risk for liver damage. University of Chicago Medicine researchers are internationally recognized for their study of gut bacteria, intestinal inflammation and the roles they play in liver fat build up.
If you’re interested in participating in our research, your doctor can work with you to find a UChicago Medicine clinical trial.
Find a Nonalcoholic Fatty Liver Disease Clinical Trial
At the University of Chicago Medicine, we’re committed to advancing discoveries that transform our patients’ lives and expand our physicians’ knowledge. Explore our active NAFLD and NASH clinical trials.See NAFLD Clinical Trials